Gaku Sakaguchi

This inventor holds 10 USPTO granted patents and 1 published patent application, plus 1 CIPO patent and 3 EPO patents. Top assignee: Shionogi Company Limited. Active years: 2000-2015.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Gaku Sakaguchi. Retrieved from https://idiyas.com/inventor/gaku-sakaguchi

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 10 (Patent Applications = 1)

% Patents Active = 20.0

CIPO Patents = 1 (Patent Applications = 1)

EPO Patents = 3 (Patent Applications = 3)

Average Co-Inventor Count = 7.4

ph-index = 3

Forward Citations = 72(Granted Patents)

Location History:

Takatsuki, JP (2000 - 2001)
Shiga, JP (2012 - 2014)
Koka, JP (2014 - 2015)

Company Filing History:

10 out of 1,001

Shionogi Company Limited

patents

Years Active: 2000-2015

Loading Chart...

10 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 9029358 - Aminodihydrothiazine derivatives (2015-05-12),

2. 8895548 - Pharmaceutical composition for treating alzheimer's disease (2014-11-25),

3. 8815851 - Aminodihydrothiazine derivatives (2014-08-26),

4. 8703785 - 2-aminopyrimidin-4-one and 2-aminopyridine derivatives both having BACE1-inhibiting activity (2014-04-22),

5. 8653067 - Pharmaceutical composition for treating Alzheimer's disease (2014-02-18),

6. 8633188 - Aminodihydrothiazine derivatives (2014-01-21),

7. 8546380 - Aminodihydrothiazine derivatives (2013-10-01),

8. 8173642 - Aminodihydrothiazine derivatives (2012-05-08),

9. 6218522 - DNA molecule relating to suppression of gene expression and novel protein (2001-04-17),

10. 6090783 - DNA molecule relating to suppression of gene expression and novel protein (2000-07-18),

Title: Gaku Sakaguchi: Innovator in Pharmaceutical Research

Introduction

Gaku Sakaguchi is a prominent inventor based in Shiga, Japan. He has made significant contributions to the field of pharmaceutical research, particularly in the development of compounds aimed at treating Alzheimer's disease. With a total of 10 patents to his name, Sakaguchi's work has garnered attention in the scientific community.

Latest Patents

Among his latest patents are innovative compositions that demonstrate BACE 1 inhibitory activity. One notable patent is focused on aminodihydrothiazine derivatives, which are essential in the development of new therapeutic agents. Additionally, he has developed a pharmaceutical composition specifically designed for treating Alzheimer's disease, which contains a compound represented by a general formula.

Career Highlights

Sakaguchi has worked with reputable companies in the pharmaceutical industry, including Shionogi & Company Limited. His experience in these organizations has allowed him to refine his expertise and contribute to groundbreaking research in drug development.

Collaborations

Throughout his career, Gaku Sakaguchi has collaborated with esteemed colleagues such as Naotake Kobayashi and Kazuo Ueda. These partnerships have facilitated the exchange of ideas and fostered innovation in their respective fields.

Conclusion

Gaku Sakaguchi's contributions to pharmaceutical research and his impressive portfolio of patents highlight his role as a key innovator in the industry. His work continues to pave the way for advancements in treatments for Alzheimer's disease and other medical conditions.

Profile summary based on public USPTO records.